subtype-selective allosteric kinase inhibitors (VM Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesubtype-selective allosteric kinase inhibitors (VM Pharma)
Drug Alias Namesmall molecule therapeutics (VM Discovery)subtype-selective allosteric kinase inhibitors (VM Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsPainCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVm Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVm DiscoveryVM Pharma LLC
Active IndicationsN/A
Inactive IndicationsPainCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A